Rare disease focus Sobi North America specializes in rare and difficult to treat diseases with protein biochemistry and biologics manufacturing capabilities, presenting opportunities to offer specialized contract development, manufacturing, and patient support services to biotechs and rare-disease-focused organizations.

North America footprint Established bases in Waltham and Toronto suggest proximity to biotech clusters and payer/HCP networks, enabling targeted outreach for collaboration on therapies in development, regulatory support, and regional clinical manufacturing needs.

Strategic partnerships Existing collaboration with Florio GmbH and emphasis on patient empowerment tools indicate openness to co-development, digital patient resources, and companion support platforms that can be co-marketed or integrated with partner programs.

Financial capacity Annual revenue in the hundred-million range signals solid funding for partnership deals, scaled clinical manufacturing, and long-term supply agreements with mid-to-large biotech clients seeking reliable biologics production.

Technology enablement technology stack including AWS, Drupal, Open Graph and OneTrust shows readiness for digital patient engagement, data governance, and scalable web/infrastructure solutions that can underpin patient registries, HCP portals, and partner collaboration ecosystems.